Starting mid-2026, you may notice that your Mounjaro® KwikPen® looks slightly different from the versions you received previously. This is an official, expected cosmetic update by the manufacturer, Eli Lilly, to improve the pen's usability.
This update only changes the external look and internal housing of the device itself. The medication inside remains completely unchanged. The active ingredient (tirzepatide), your prescribed dose strength, and how you inject your medication remain exactly the same.
Use this article if you want to:
Understand what visual changes to expect on your next Mounjaro® delivery.
Confirm how the new plunger alignment looks before and after use.
Learn how to differentiate a normal cosmetic update from a genuine device fault.
What Has Changed in the Pen’s Design?
During a temporary transition period, you may receive either the original pen design or the updated pen design depending on stock availability. Both versions are fully approved, authentic, and completely safe to use.
If you receive the updated pen style, you will notice three main visual differences:
Initial Plunger Position: Before your very first use, the grey plunger may sit slightly lower in the glass window than it did on previous pens. This is part of the design change and does not mean your pen is missing medication—it still contains four full, accurate doses.
Internal Components: Certain moving parts inside the window mechanism, including a longer internal extension piece behind the plunger, have been altered.
Clearer End-of-Use Indicator: Once you have injected your fourth and final dose, the plunger will extend much further down, sitting near the very end of the cartridge. This provides a clear visual confirmation that the pen is completely finished and ready to be thrown away.
What Has NOT Changed?
Because this is purely a manufacturing update to the plastic pen casing and internal track system, there are no changes to your actual medical treatment.
No change to the liquid medication formulation or its effectiveness.
No change to your weekly injection process or priming instructions.
No change to the number of doses (each pen still holds exactly 4 doses).
No change to the safety profile of your treatment.
The "Fifth Dose" / Leftover Liquid Warning
Some patients online refer to leftover medication visible in the glass window after the final injection as a "golden dose" or "fifth dose."
Please be aware that the Mounjaro® KwikPen® is manufactured to deliver four fixed doses only. Any residual liquid left in the chamber after your fourth injection is a safety buffer, is not a managed dose, and is not intended for use. You should never attempt to extract, siphon, or inject this leftover liquid. The updated pen design has been explicitly changed to help you see when your 4 legal doses are finished so you can safely discard the pen.
How to Identify a Genuine Pen Fault
While a change in the position of the plunger or a different look to the internal plastic parts is completely normal, you should still monitor your pen for operational defects.
Normal Appearance Changes (No Action Required):
The grey plunger looks lower down the window than usual before the first dose.
The internal tracking rod behind the plunger looks longer or different.
The plunger rests completely at the bottom of the glass window after the 4th dose.
Genuine Product Issues (Contact Customer Support):
The pen arrives with cracked plastic casing, a broken mechanism, or a damaged outer box.
The dose selector dial is jammed or will not turn.
The pen will not prime correctly during your initial flow check.
Liquid is leaking heavily from the side of the pen or failing to deploy from the needle tip.
If your pen appears physically broken or fails to deploy your dose correctly during injection, please leave the pen as it is and contact our Customer Care Team for support. For all standard appearance variations, you can confidently continue your weekly dosing schedule exactly as normal.
If you still need help after reviewing the information above, additional assistance is available.